New HR-HPV Testing Methodology October 4th, 2021

P & C Labs is pleased to announce we are improving our HR-HPV testing! With increased sensitivity and specificity, the Hologic Panther is the industry standard. Hologic’s Panther platform is built on mRNA-based HPV testing. All HR-HPV testing will be automatically reflexed to genotyping.

HR-HPV testing will now be reported as:

HR-HPV POOL: Positive/Negative

HPV 16: Positive/Negative

HPV 18/45: Positive/Negative


The Aptima HPV 16, 18/45 Genotype Assay: HPV types 16, 18 and 45 are associated with up to 94% of HPV-related cervical adenocarcinomas.   

The Aptima mRNA HPV assay’s targeted approach identifies HR-HPV infections that are both present and active, reducing the need for unnecessary patient call backs and overtreatment. Aptima HPV targets E6/E7 mRNA expression, which is indicative of the HPV infections most likely to lead to disease.

Testing will be done directly from the ThinPrep vial. Our Pathologists and staff are always available to answer your questions about our testing and services. We look forward to helping you provide quality care for your patients. If you have any questions, please contact client services at (859) 278-9513.

Originally Published on Thursday, September 23, 2021